RxDoctor Payments Data

Daniel Coelho, MD

Otolaryngology · Richmond, VANPI 1477714756

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Oticon Medical, LLC at 47.4% of the total. Reporting peaked in 2024 at $5,583 and has fallen 77.8% since, to $1,240 in 2025. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,364in general payments, 2019–2025

Across 61 payments — averaging $153.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Oticon Medical, LLC$4K
  • KARL Storz Endoscopy-america$2K
  • Stryker$1K
  • Aerin Medical Inc.$472
  • Med-el Corporation$325
  • Cochlear Americas$302
  • plus $448 from 4 others
$37,607in research payments, 2019–2025

Across 13 payments — averaging $2892.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$38K

What the payments were for

  • Consulting fees$2,03222%
  • Travel & lodging$2,72729%
  • Food & beverage$4,60649%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,364 in reported general payments places this provider in the 90th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$107,010
Medicare patients
211
Services billed
502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nortriptyline Hcl16$196
Omeprazole14$15

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →